Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors
- 31 July 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (1) , 25-34
- https://doi.org/10.1016/s0002-9440(10)63272-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Post-transcriptional Regulation of the Sodium/Iodide Symporter by ThyrotropinJournal of Biological Chemistry, 2001
- Expression of the Sodium Iodide Symporter and Thyroglobulin Genes Are Reduced in Papillary Thyroid CancerLaboratory Investigation, 2001
- Management of undifferentiated thyroid cancerBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- Expressions of Human Sodium Iodide Symporter mRNA in Primary and Metastatic Papillary Thyroid CarcinomasThyroid®, 2000
- N-linked Glycosylation of the Thyroid Na+/I− Symporter (NIS)Journal of Biological Chemistry, 1998
- Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.Journal of Clinical Investigation, 1998
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996
- Cloning and characterization of the thyroid iodide transporterNature, 1996
- Gene Expression of Differentiation- and Dedifferentiation Markers in Normal and Malignant Human Thyroid TissuesExperimental and Clinical Endocrinology & Diabetes, 1992
- Human thyrotropin receptor gene: Expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiationMolecular and Cellular Endocrinology, 1991